Abstract 463P
Background
T factor depends on consolidation diameter in lung adenocarcinoma. Adenocarcinoma with short consolidation diameter could be indicated for sublobar resection. However, measurement of consolidation diameter under lung window in 2D-CT could be problematic, as the outline is not clear. We evaluated the relationship between consolidation lesion under mediastinal window in 3D-CT and pathological invasiveness, and aimed to predict invasiveness using machine learning algorithm.
Methods
Ninety-five patients who underwent surgical resection of lung adenocarcinoma that is less than 20 mm in diameter and has consolidation were analyzed retrospectively, in our Hospital from 2010 to 2016. The total tumor diameter and the volume and diameter of consolidation were analyzed using thin-slice CT and 3D-CT. Preoperative FDG-PET and serum CEA were also measured. Preinvasive lesion and minimally invasive adenocarcinoma were classified as pathologically non-invasive group, and invasive adenocarcinoma was classified as pathologically invasive group. The statistical differences were assessed by the Mann-Whitney U test or chi-square test. We used two machine learning algorithm. Three logistic regression (LR) models were trained based on sex, total tumor diameter, SUVmax, CEA, and (1) consolidation diameter (LR-Cd), (2) consolidation volume (LR-Cv), (3) consolidation diameter and volume (LD-Cd+Cv). Similarly, three random forest (RF) models were trained (RF-Cd, RF-Cv, RF-Cd+Cv). Patients were split into a training set (n = 76) and test set (n = 19). Model performance was measured area under the curve (AUC), and compared using receiver-operating characteristics curve analysis on the test set.
Results
Twenty-six non-invasive adenocarcinomas and 69 invasive adenocarcinomas were evaluated. The consolidation diameter and volume, and SUVmax of invasive group were significantly greater than those of non-invasive group (p < 0.001). On the test set, AUC of LR-Cd, RF-Cd, LR-Cv, RF-Cv, LR-Cd+Cv and RF-Cd+Cv were 0.687, 0.703,0.628, 0.744, 0.628 and 0.744 respectively.
Conclusions
The pathological invasiveness could be predicted by using machine learning algorithm. Especially, higher AUCs were obtained in RF-Cv and RF-Cd+Cv model.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
117P - Short-term and long-term outcomes of hepatectomy combined with intraoperative radiofrequency ablation for multiple colorectal liver metastases: A propensity score matching study
Presenter: Wenbai Huang
Session: Poster display session
Resources:
Abstract
119P - The impacts of dose-time-fractionation schedules on pathological complete response rate (pCR) and local recurrence (LR)
Presenter: Fu Jin
Session: Poster display session
Resources:
Abstract
120P - Platelet to lymphocyte ratio is associated with tumour localization and outcomes in patients with metastatic colorectal cancer
Presenter: Ahmet Bilici
Session: Poster display session
Resources:
Abstract
121P - Meta-analysis of three-dimensional versus two-dimensional laparoscopic surgery for rectal cancer
Presenter: Laiyuan Li
Session: Poster display session
Resources:
Abstract
127P - Outcomes based on albumin‐bilirubin (ALBI) grade in the phase III CELESTIAL trial of cabozantinib versus placebo in patients with advanced hepatocellular carcinoma (HCC)
Presenter: Stephen Chan
Session: Poster display session
Resources:
Abstract
128P - Tislelizumab in combination with chemotherapy for Chinese patients (Pts) with gastric/gastroesophageal junction cancer (GC/GEJC) or esophageal squamous cell carcinoma (ESCC)
Presenter: Yuxian Bai
Session: Poster display session
Resources:
Abstract
129P - Monitoring patient-specific mutation in ctDNA and CTC for tumour response evaluation after neoadjuvant chemotherapy in advanced gastric adenocarcinoma (NCT03425058)
Presenter: Tao Fu
Session: Poster display session
Resources:
Abstract
130P - Development of a liver cancer risk prediction model for the general population in china: A potential tool for screening
Presenter: Xiaoshuang Feng
Session: Poster display session
Resources:
Abstract
131P - Cabozantinib in Asian patients with hepatocellular carcinoma and other solid tumours: Population pharmacokinetics analysis
Presenter: Chih-Hung Hsu
Session: Poster display session
Resources:
Abstract
132P - Liposomal irinotecan (nal-IRI) plus 5-fluorouracil/levoleucovorin (5 FU/LV) vs 5-FU/LV in Japanese patients (pts) with gemcitabine-refractory metastatic pancreatic cancer (mPAC)
Presenter: Tatsuya Ioka
Session: Poster display session
Resources:
Abstract